ArticleBMJ open2022

Feasibility of a new electronic patient-reported outcome (ePRO) system for an advanced therapy clinical trial in immune-mediated inflammatory disease (PROmics): protocol for a qualitative feasibility study.

Sarah E Hughes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.